Volume 96 Issue 12 | p. 13 | Concentrates
Issue Date: March 19, 2018

Changing of research guard at Gilead

Department: Business
Keywords: Employment, Gilead, Bischofberger
[+]Enlarge
Bischofberger
Credit: Gilead Sciences
Photo of Norbert Bischofberger, CSO of Gilead.
 
Bischofberger
Credit: Gilead Sciences

Norbert Bischofberger, head of R&D and chief scientific officer of Gilead Sciences, is stepping down at the end of April. Bischofberger, a chemist by training, has been at Gilead for nearly three decades, overseeing research during the development of its lucrative hepatitis C drug portfolio. In total, Gilead commercialized more than 25 compounds during his tenure. John McHutchison, currently Gilead’s vice president of clinical research, will take over as research chief.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment